Variant report
Variant | nsv429991 |
---|---|
Chromosome Location | chr1:189942242-189984913 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:180)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr1:189969460-189970122 | A549 | lung: | n/a | chr1:189969632-189969641 chr1:189969514-189969523 |
2 | CEBPB | chr1:189966523-189966870 | IMR90 | lung: | n/a | chr1:189966685-189966696 |
3 | CEBPB | chr1:189966553-189966843 | A549 | lung: | n/a | chr1:189966685-189966696 |
4 | CEBPB | chr1:189966592-189966813 | MCF-7 | breast: | n/a | chr1:189966685-189966696 |
5 | CEBPB | chr1:189969426-189970047 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr1:189966532-189966826 | HepG2 | liver: | n/a | chr1:189966685-189966696 |
7 | CEBPB | chr1:189969527-189969898 | IMR90 | lung: | n/a | n/a |
8 | CEBPB | chr1:189951723-189951923 | IMR90 | lung: | n/a | chr1:189951847-189951858 |
9 | CEBPB | chr1:189969579-189969895 | A549 | lung: | n/a | n/a |
10 | CEBPB | chr1:189984024-189984217 | IMR90 | lung: | n/a | n/a |
11 | CEBPB | chr1:189966602-189966802 | K562 | blood: | n/a | chr1:189966685-189966696 |
12 | CEBPB | chr1:189951683-189951980 | HepG2 | liver: | n/a | chr1:189951847-189951858 |
13 | CEBPB | chr1:189966558-189966824 | H1-hESC | embryonic stem cell: | n/a | chr1:189966685-189966696 |
14 | CTCF | chr1:189958540-189958690 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr1:189946420-189946570 | A549 | lung: | n/a | n/a |
16 | CTCF | chr1:189961252-189961345 | K562 | blood: | n/a | n/a |
17 | CTCF | chr1:189946308-189946580 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | CTCF | chr1:189946485-189946558 | GM12891 | blood: | n/a | n/a |
19 | CTCF | chr1:189978420-189978570 | WI-38 | lung: | n/a | n/a |
20 | CTCF | chr1:189946440-189946590 | GM12864 | blood: | n/a | n/a |
21 | CTCF | chr1:189946420-189946570 | GM12869 | blood: | n/a | n/a |
22 | CTCF | chr1:189946440-189946590 | GM12868 | blood: | n/a | n/a |
23 | CTCF | chr1:189946520-189946670 | BE2_C | brain: | n/a | n/a |
24 | CTCF | chr1:189946440-189946590 | GM12865 | blood: | n/a | n/a |
25 | CTCF | chr1:189946463-189946539 | K562 | blood: | n/a | n/a |
26 | CTCF | chr1:189946380-189946530 | GM12867 | blood: | n/a | n/a |
27 | CTCF | chr1:189946400-189946550 | HepG2 | liver: | n/a | n/a |
28 | CTCF | chr1:189946496-189946509 | MCF-7 | breast: | n/a | n/a |
29 | CTCF | chr1:189946478-189946559 | GM13977 | blood: | n/a | n/a |
30 | CTCF | chr1:189946429-189946562 | HepG2 | liver: | n/a | n/a |
31 | CTCF | chr1:189946458-189946546 | A549 | lung: | n/a | n/a |
32 | CTCF | chr1:189946440-189946590 | GM12874 | blood: | n/a | n/a |
33 | CTCF | chr1:189946461-189946570 | GM12878 | blood: | n/a | n/a |
34 | CTCF | chr1:189958560-189958710 | HCPEpiC | choroid plexus: | n/a | n/a |
35 | CTCF | chr1:189946420-189946570 | GM12866 | blood: | n/a | n/a |
36 | CTCF | chr1:189946437-189946582 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | CTCF | chr1:189946440-189946590 | HEK293 | kidney: | n/a | n/a |
38 | CTCF | chr1:189946440-189946590 | GM12872 | blood: | n/a | n/a |
39 | CTCF | chr1:189946460-189946610 | GM12871 | blood: | n/a | n/a |
40 | CTCF | chr1:189946460-189946610 | GM12864 | blood: | n/a | n/a |
41 | CTCF | chr1:189980816-189980870 | GM10266 | blood: | n/a | n/a |
42 | CTCF | chr1:189946464-189946538 | MCF-7 | breast: | n/a | n/a |
43 | CTCF | chr1:189946445-189946559 | Gliobla | brain: | n/a | n/a |
44 | CTCF | chr1:189958840-189958990 | HepG2 | liver: | n/a | n/a |
45 | CTCF | chr1:189946463-189946546 | GM12892 | blood: | n/a | n/a |
46 | CTCF | chr1:189946480-189946630 | Hela-S3 | cervix: | n/a | n/a |
47 | CTCF | chr1:189946440-189946590 | GM12875 | blood: | n/a | n/a |
48 | CTCF | chr1:189946440-189946590 | GM12873 | blood: | n/a | n/a |
49 | CTCF | chr1:189961249-189961379 | K562 | blood: | n/a | n/a |
50 | CTCF | chr1:189946474-189946548 | GM19238 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM5C-5 | chr1:189958700-189962227 | NONHSAT008489 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230987 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1320749 | chr1:189942242-189942243 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs139997555 | chr1:189942285-189942286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561806747 | chr1:189942286-189942287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148919000 | chr1:189942327-189942328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1320750 | chr1:189942336-189942337 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs7340028 | chr1:189942402-189942403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75706456 | chr1:189942427-189942428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533471295 | chr1:189942434-189942435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549933341 | chr1:189942467-189942468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1730735 | chr1:189942493-189942494 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs551713263 | chr1:189942503-189942504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529479576 | chr1:189942509-189942510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115762622 | chr1:189942539-189942540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550840905 | chr1:189942541-189942542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555001129 | chr1:189951610-189951611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116715627 | chr1:189951631-189951632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535079029 | chr1:189951635-189951636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553297276 | chr1:189951636-189951637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550969512 | chr1:189951643-189951644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576861858 | chr1:189951668-189951669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78748809 | chr1:189951683-189951684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558470804 | chr1:189951695-189951696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138424503 | chr1:189951709-189951710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs80218384 | chr1:189951741-189951742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571240329 | chr1:189951756-189951757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561006271 | chr1:189951777-189951778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368860078 | chr1:189951779-189951780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12401820 | chr1:189951793-189951794 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs560173112 | chr1:189951808-189951809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566773898 | chr1:189951810-189951811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532182052 | chr1:189951817-189951818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536938185 | chr1:189951860-189951861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149409497 | chr1:189951891-189951892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569573497 | chr1:189951894-189951895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs815725 | chr1:189951950-189951951 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs548511182 | chr1:189951993-189951994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568512937 | chr1:189952016-189952017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534020616 | chr1:189952042-189952043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536496308 | chr1:189952087-189952088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs815726 | chr1:189952094-189952095 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs192798744 | chr1:189952101-189952102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539452277 | chr1:189952121-189952122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144760765 | chr1:189952170-189952171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116089999 | chr1:189952172-189952173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544368448 | chr1:189952214-189952215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554447426 | chr1:189952234-189952235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115767255 | chr1:189952241-189952242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185250135 | chr1:189952271-189952272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560333417 | chr1:189952294-189952295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558654374 | chr1:189952299-189952300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:189940800-189942600 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr1:189951600-189952200 | Enhancers | Fetal Intestine Small | intestine |
3 | chr1:189951800-189952000 | Enhancers | Fetal Intestine Large | intestine |
4 | chr1:189952000-189952600 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr1:189952200-189952600 | Weak transcription | Fetal Intestine Small | intestine |
6 | chr1:189952600-189953800 | Enhancers | Fetal Intestine Large | intestine |
7 | chr1:189952600-189954000 | Enhancers | Fetal Intestine Small | intestine |
8 | chr1:189952800-189953800 | Enhancers | Duodenum Mucosa | Duodenum |
9 | chr1:189955600-189956200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr1:189956000-189956800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr1:189968400-189969600 | Enhancers | A549 | lung |
12 | chr1:189969400-189970600 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr1:189969600-189969800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr1:189969600-189970600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr1:189969600-189970600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr1:189969600-189970600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr1:189969600-189970600 | Flanking Active TSS | A549 | lung |
18 | chr1:189969800-189970400 | Enhancers | Hela-S3 | cervix |
19 | chr1:189970000-189970400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr1:189970200-189971000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr1:189970400-189970600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr1:189970600-189970800 | Enhancers | A549 | lung |
23 | chr1:189979000-189979400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
24 | chr1:189983000-189986200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |